Laboratory testing revealed hypoalbuminemia and mild anemia; liver function tests and tumor markers, including carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), were within normal limits. The gene discussed is CEACAM5; the disease is anemia.